FMTX insider filings

Forma Therapeutics Holdings, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-10-14. Screen FMTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for FMTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Forma Therapeutics Holdings, Inc.

FiledFormInsiderReported transactionsSource
2022-10-144Lesser Brian Andrew — SVP, Commercial OfficerCode (U): 10,000 · Code (U): 42,593 · Disposition to issuer (D): 32,987 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 46,756 (derivative) · Disposition to issuer (D): 46,756 (derivative) · +2 moreEDGAR
2022-10-144Potts Jeannette — See RemarksCode (U): 3,400 · Code (U): 43,958 · Disposition to issuer (D): 111,746 (derivative) · Disposition to issuer (D): 11,689 (derivative) · Disposition to issuer (D): 105,201 (derivative) · Disposition to issuer (D): 72,004 (derivative) · +2 moreEDGAR
2022-10-144Frederick Wayne A.I. — DirectorCode (U): 7,250 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative)EDGAR
2022-10-144Lee Frank D. — President and CEO, DirectorCode (U): 201,436 · Disposition to issuer (D): 678,357 (derivative) · Disposition to issuer (D): 70,134 (derivative) · Disposition to issuer (D): 748,100 (derivative) · Disposition to issuer (D): 71,770 (derivative) · Disposition to issuer (D): 175,875 (derivative) · +1 moreEDGAR
2022-10-144Melian Agustin — EVP, Research & DevelopmentCode (U): 79,000 · Disposition to issuer (D): 118,000 (derivative)EDGAR
2022-10-144Shegog Todd — SVP, Chief Financial OfficerCode (U): 56,143 · Disposition to issuer (D): 153,528 (derivative) · Disposition to issuer (D): 11,689 (derivative) · Disposition to issuer (D): 116,890 (derivative) · Disposition to issuer (D): 70,134 (derivative) · Disposition to issuer (D): 50,250 (derivative) · +1 moreEDGAR
2022-10-144MOLINA ARTURO MD — DirectorCode (U): 10,000 · Disposition to issuer (D): 16,750 (derivative) · Disposition to issuer (D): 6,750 (derivative)EDGAR
2022-10-144RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner
Code (U): 7,250 · Code (U): 7,500,226 · Code (U): 1,511,425 · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative)EDGAR
2022-10-144Bishop John E — SVP, Chief Technology OfficerCode (U): 47,950 · Disposition to issuer (D): 67,000 (derivative) · Disposition to issuer (D): 38,930 (derivative)EDGAR
2022-10-144Fanucci Marsha — DirectorCode (U): 52,532 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · +1 moreEDGAR
2022-10-144CLACKSON TIMOTHY P — DirectorCode (U): 23,590 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 9,351 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · +2 moreEDGAR
2022-10-144WIGGANS THOMAS G — DirectorCode (U): 7,250 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative)EDGAR
2022-10-144WIRTH PETER — DirectorCode (U): 127,665 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · +1 moreEDGAR
2022-07-124Melian Agustin — EVP, Research & DevelopmentGrant/award (A): 79,000 @ $0 · Grant/award (A): 118,000 (derivative) @ $0EDGAR
2022-06-094Frederick Wayne A.I. — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094Vickers Selwyn M MD — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094MOLINA ARTURO MD — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094Fanucci Marsha — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094CLACKSON TIMOTHY P — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094WIGGANS THOMAS G — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-06-094WIRTH PETER — DirectorGrant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2022-04-144Kelly Patrick F. — SVP, Chief Medical OfficerOption exercise (M): 15,000 @ $5.05 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2022-03-024Lesser Brian Andrew — SVP, CommercialGrant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2022-03-024Lee Frank D. — President and CEO, DirectorGrant/award (A): 121,667 @ $0 · Grant/award (A): 182,500 (derivative) @ $0EDGAR
2022-03-024Kelly Patrick F. — SVP, Chief Medical OfficerGrant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2022-03-024Shegog Todd — SVP, Chief Financial OfficerGrant/award (A): 33,330 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-024Potts Jeannette — See RemarksGrant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2022-03-024Bishop John E — SVP, Chief Technology OfficerGrant/award (A): 25,950 @ $0 · Grant/award (A): 38,930 (derivative) @ $0EDGAR
2022-03-024COOK DAVID N — SVP, Chief Scientific OfficerGrant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2022-02-254Lee Frank D. — President and CEO, DirectorSale (S): 17,981 @ $9.78EDGAR
2022-02-254Kelly Patrick F. — SVP, Chief Medical OfficerSale (S): 5,245 @ $9.78EDGAR
2022-02-254Shegog Todd — SVP, Chief Financial OfficerSale (S): 5,687 @ $9.78EDGAR
2022-02-254Lesser Brian Andrew — SVP, CommercialSale (S): 3,837 @ $9.78EDGAR
2022-02-254Wadlinger Mary E. — See RemarksSale (S): 4,684 @ $9.78EDGAR
2022-02-254Potts Jeannette — See RemarksSale (S): 4,672 @ $9.78EDGAR
2022-02-254COOK DAVID N — SVP, Chief Scientific OfficerSale (S): 3,531 @ $9.78EDGAR
2022-01-134MOLINA ARTURO MD — DirectorGrant/award (A): 5,500 @ $0 · Grant/award (A): 16,750 (derivative) @ $0EDGAR
2021-06-214Vickers Selwyn M MD — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214Frederick Wayne A.I. — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214Kolchinsky Peter — Director, 10% ownerGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214Fanucci Marsha — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214CLACKSON TIMOTHY P — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214WIGGANS THOMAS G — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-214WIRTH PETER — DirectorGrant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0EDGAR
2021-06-154Bishop John E — Chief Technology OfficerGrant/award (A): 22,000 @ $0 · Grant/award (A): 67,000 (derivative) @ $0EDGAR
2021-04-054RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner
Other (J): 542,018 @ $28.02EDGAR
2021-03-024Shegog Todd — SVP, Chief Financial OfficerGrant/award (A): 16,500 @ $0 · Grant/award (A): 12,000 @ $0 · Grant/award (A): 50,250 (derivative) @ $0EDGAR
2021-03-024Lee Frank D. — President and CEO, DirectorGrant/award (A): 57,750 @ $0 · Grant/award (A): 40,000 @ $0 · Grant/award (A): 175,875 (derivative) @ $0EDGAR
2021-03-024Kelly Patrick F. — Chief Medical OfficerGrant/award (A): 16,500 @ $0 · Grant/award (A): 10,670 @ $0 · Grant/award (A): 50,250 (derivative) @ $0EDGAR
2021-03-024COOK DAVID N — SVP, Chief Scientific OfficerGrant/award (A): 14,300 @ $0 · Grant/award (A): 5,700 @ $0 · Grant/award (A): 43,550 (derivative) @ $0EDGAR

Recent 8-K events — Forma Therapeutics Holdings, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-10-148-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-018-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-07-258-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-06-098-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2022-05-268-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-018-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-12-168-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FMTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs